The American Heart Association (AHA) Scientific Sessions this year (November 13 – 15, 2021) will include presentations by:
Shamir Mehta, PHRI Senior Scientist, Douglas Holder/PHRI Chair in Interventional Cardiology, and head of the ACS and Interventional Cardiology research program at PHRI, has two on-demand sessions:
- In Debates in the Management of NSTEACs, Dr. Mehta will argue (Pro): All high-risk patients with NSTEACS should undergo immediate/early angiography, vs Thomas Engstrom, Denmark (Con).
- In STEMI and Hot Topics, Dr. Mehta presents on STEMI and MVD: COMPLETE revascularization timing, imaging, and more, on Sat. Nov. 13.
Guillaume Pare, PHRI Senior Scientist and Director, CRLB-GMEL, will present the on-demand presentation, Discovery of Novel Causal Mediators Using Biobanks and Multi-omics Technologies, part of the session, The Era of Multi-Omics for Cardiovascular Disease, Sat. Nov. 13.
Member of the CRLB-GMEL, PhD student Tafadzwa Machipisa participated in the AHA session, New Data in Genomic Science session with her presentation, “Analysis Suggests Enrichment of Heart Valve Tissue Expression in African Rheumatic Heart Disease Patients From the RHDGen GWAS Study Cohort” based on the 2021 JAMA Cardiology publication she coauthored with Gui Pare and University of Cape Town scientists.
PHRI Scientist Harriette Van Spall will participate in the session, A Roadmap to Closing the Gender Gap in Cardiovascular Clinical Trial Leadership on Nov. 13. She will present on Diversity Gap: Culprits, Consequences, and a Roadmap for Change.
You can follow breaking news about AHA Scientific Sessions on Twitter using the hashtag #AHA21.